OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dassault Systèmes | BIOVIA Materials Studio products | unaffected |
|
No data.
No data available yet.
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2023-58334 | An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution. |
No CVSS v4.0
No CVSS v3.0
No CVSS v2
This CVE is not in the KEV list.
Exploit prediction score: 1.6% (1.643% probability within 30 days)
| Link | Providers |
|---|---|
| https://www.3ds.com/vulnerability/advisories |
|
| Type | Values Removed | Values Added |
|---|---|---|
| Metrics |
ssvc
|